🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,589 results for “Pharma” Clear

  1. Mavorixafor

    X4 Pharmaceuticals, Inc

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  2. Meloxicam 15 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  3. Methotrexate - Amneal

    Amneal Pharma Europe Ltd

    Psoriasis

    phase 1 small molecule active

    1 trial

  4. Methotrexate PK (in combination with Novobiocin) in RA patients

    Lacuna Pharma Pty Ltd

    Rheumatoid arthritis

    phase 1 other active

    1 trial

  5. Metronidazole

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  6. Microgestin®

    IRONWOOD PHARMACEUTICALS INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  7. Midazolam

    ENANTA PHARMACEUTICALS INC

    NASH

    phase 1 small molecule completed

    1 trial

  8. Midazolam Syrup

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  9. Minzasolmin, UCB0599 PRD4385815

    Lacuna Pharma Pty Ltd

    Healthy Participants

    phase 1 small molecule active

    1 trial

  10. Mirtazapine 15 mg (Orally Disintegrating) Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  11. Moexipril HCl/hydrochlorothiazide 15/25 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  12. Mycophenolate Mofetil

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    4 trials

  13. NCO-48 Fumarate

    LIGAND PHARMACEUTICALS INC

    Hepatitis B

    phase 1 small molecule completed

    1 trial

  14. NCO-48 Fumarate 4 mg

    LIGAND PHARMACEUTICALS INC

    Chronic Hepatitis B

    phase 1 small molecule completed

    1 trial

  15. NKTR-214 (Cohort A)

    INOVIO PHARMACEUTICALS, INC.

    Metastatic Castration-resistant Prostate Cancer

    phase 1 small molecule completed

    1 trial

  16. NP101

    Teva Pharma GmbH

    Compare Bioequivalence Patches Previously Used in the NP101-007 Study

    phase 1 small molecule completed

    1 trial

  17. NPC-22

    Belpharma s.a.

    Safety and Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  18. NPC-22

    Belpharma s.a.

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial

  19. NTQ5082 capsule

    Nanjing Chia-tai Tianqing Pharmaceutical

    Complement-mediated Hemolytic Diseases

    phase 1 small molecule active

    1 trial

  20. NXP800 in subjects with Ovarian Cancer

    Lacuna Pharma Pty Ltd

    Platinum-resistant, ARID1a-mutated ovarian, fallopian tube and primary peritoneal carcinoma

    phase 1 other active

    1 trial

  21. Nafamostat Mesilate

    BRIGHT MINDS BIOSCIENCES INC.

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  22. NatrunixTM

    XBiotech Germany GmbH

    Pharmacokinetics

    phase 1 mab active

    1 trial

  23. Nevirapine

    Teva Pharma GmbH

    HIV-1

    phase 1 small molecule completed

    1 trial

  24. Nezulcitinib (TD-0903) Dose A

    Theravance Biopharma Ireland Umited

    Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19)

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources